Potential drug to target a rare childhood brain tumour – ICR

The Institute of Cancer Research (ICR) shared a post on LinkedIn:

“News: Research reveals a potential drug to target a rare childhood brain tumour.

ICR scientists and Dana-Farber Cancer Institute found a key weakness in the tumour cells which could be targeted by ribociclib, a drug already used to treat breast cancer.

Read more about the research, funded by The Brain Tumour Charity.”

Source: The Institute of Cancer Research/LinkedIn

More posts featuring The Institute of Cancer Research on oncodaily.com